1
|
Weverling F, Roeven M, Nijssen C, Broers AEC, Dovern E, van Rhenen A, Sluis GV, Hazenberg CLE, Balen PV, Kuipers MT, de Vooght KMK, Morsink L, Kuball J, Nur E, de Witte MA. Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data. Blood Adv 2024; 8:1683-1686. [PMID: 38231018 PMCID: PMC11006807 DOI: 10.1182/bloodadvances.2023011190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Revised: 11/13/2023] [Accepted: 11/30/2023] [Indexed: 01/18/2024] Open
Affiliation(s)
- Flores Weverling
- Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Mieke Roeven
- Department of Hematology, Radboud University Medical Center; Nijmegen, The Netherlands
| | - Clara Nijssen
- Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Annoek E. C. Broers
- Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
| | - Elisabeth Dovern
- Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Anna van Rhenen
- Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Geerte van Sluis
- Department of Hematology, Isala Hospital, Zwolle, The Netherlands
| | - Carin L. E. Hazenberg
- Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands
| | - Peter van Balen
- Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands
| | - Maria T. Kuipers
- Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Karen M. K. de Vooght
- Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Linde Morsink
- Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands
| | - Jürgen Kuball
- Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Erfan Nur
- Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands
| | - Moniek A. de Witte
- Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands
| |
Collapse
|
2
|
Cany J, Roeven M, Hoogstad-vanEvert J, Maas F, FrancoFernandez R, Blijlevens N, Jansen J, Huls G, Schaap N, Dolstra H. Decitabine enhances targeting of acute myeloid leukemia cells by umbilical cord blood CD34 + progenitor-derived NK cells. Cytotherapy 2017. [DOI: 10.1016/j.jcyt.2017.02.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|